Evidence map›Paper›PMID 29932143›Full record

ReviewNutrients2018

A Balanced Risk-Benefit Analysis to Determine Human Risks Associated with Pyrrolizidine Alkaloids (PA)-The Case of Herbal Medicinal Products Containing St. John's Wort Extracts (SJW).

Michael Habs, Karin Binder, Stefan Krauss, Karolina Müller, Brigitte Ernst, Luzia Valentini, Michael Koller

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Michael HabsFaculty of Medicine, LMU-University of Munich, 80336 Munich, Germany. info@michael-habs.de.
Karin BinderDidactics of Mathematics, University of Regensburg, 93053 Regensburg, Germany. karin.binder@mathematik.uni-regensburg.de.ORCID 0000-0003-0416-3029
Stefan KraussDidactics of Mathematics, University of Regensburg, 93053 Regensburg, Germany. stefan.krauss@mathematik.uni-regensburg.de.
Karolina MüllerCenter for Clinical Studies, University Hospital Regensburg, 93053 Regensburg, Germany. karolina.mueller@ukr.de.
Brigitte ErnstGeneral Medicine Unit, University Hospital Regensburg, 93053 Regensburg, Germany. dr.b.ernst@t-online.de.
Luzia ValentiniInstitute of Evidence-Based Dietetics, University of Applied Sciences Neubrandenburg, 17033 Neubrandenburg, Germany. valentini@hs-nb.de.
Michael KollerCenter for Clinical Studies, University Hospital Regensburg, 93053 Regensburg, Germany. michael.koller@ukr.de.
University Hospital Regensburg · DEUniversity of Regensburg · DELudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPyrrolizidine alkaloids (PA) exist ubiquitously in our environment. More than 6000 plants, about 3% of the world’s flowering plants, are known to synthesize PA. As a consequence, many herbal ingredients, including St. John’s wort (SJW), are contaminated with PA that can possess acute and subchronic toxic effects as well as mutagenic and genotoxic properties. Therefore, the possible benefits of SJW as an herbal remedy against depression need to be weighed against the possible risks of unwanted PA intake.

methodsWe searched the literature regarding the current knowledge on PA and evaluated the evidence on the antidepressant effects of quantified SJW extract based on a Cochrane Review and the current practice guidelines on depression. Risks are depicted in form of a risk ladder and benefits in form of an icon array.

resultsEvidence from clinical studies indicates that quantified SJW extract is an effective treatment option for mild to moderate depression with fewer side effects than conventional antidepressants. Health statistics from different countries do not quantify cases of death caused by PA intake. However, deaths due to suicide, often triggered by depression, are common (11 in 1000 in Germany in 2015) and rank between fatalities due to liver diseases (16 in 1000) and household accidents (10 in 1000).

conclusionsQuantified SJW extract is a safe and effective treatment option, and its potential of treating depression outweighs the (hypothetical) risk of unwanted PA intake.

Indexed as

PhytotherapyAntidepressive AgentsDepressionHumansHypericumPlant ExtractsPlants, MedicinalPyrrolizidine AlkaloidsRisk AssessmentTreatment OutcomeAntidepressive AgentsPlant ExtractsPyrrolizidine Alkaloidspyrrolizidine alkaloids (PA)risk-benefit analysisSt. John’s wort extract (SJW)

Identifiers

PMID29932143
PMCPMC6073194
OpenAlexW2809173139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.